1 January 2017 in Stem Cells International
Ischemic stroke is one of the leading causes of human death and disability worldwide. So far, ultra-early thrombolytic therapy is the most effective treatment. However, most patients still live with varying degrees of neurological dysfunction due to its narrow therapeutic time window. It has been confirmed in many studies that endothelial progenitor cells (EPCs), as a kind of adult stem cells, can protect the neurovascular unit by repairing the vascular endothelium and its secretory function, which contribute to the recovery of neurological function after an ischemic stroke. This paper reviews the basic researches and clinical trials of EPCs especially in the field of ischemic stroke and addresses the combination of EPC application with new technologies, including neurovascular intervention, synthetic particles, cytokines, and EPC modification, with the aim of shedding some light on the application of EPCs in treating ischemic stroke in the future.
5 February 2018 in International Journal of Neuroscience
Objective: To analyze the clinical features, diagnostic strategies and therapeutic methods associated with paraneoplastic neurological syndromes. Methods: A retrospective study of paraneoplastic neurological syndromes was performed at a single center in Shandong, East China. The medical records and follow-up data of 28 patients were intensively reviewed between February 2011 and December 2014. Results: Twenty-four (85.7%) patients experienced subacute or chronic onset of disease, and the most common symptoms reported were mild myasthenia and paresthesias. Twenty-five (89.3%) patients presented nervous system lesions prior to occult tumors, and the median time frame between paraneoplastic neurological syndromes onset and the diagnosis of a tumor was 15 weeks. Sensorimotor neuropathy, Lambert-Eaton myasthenic syndrome and limbic encephalitis were the three most common neurological syndromes reported. Elevated serum tumor markers were observed in 44.0% of patients, while 40.7% of patients were positive for onconeural antibodies. Tumors were detected in 21 (75.0%) patients after repeated whole-body screening, and lung carcinomas were the most common primary tumor detected. Seventeen patients received anti-tumor or immunological therapy, and clinical symptoms were relieved in 13 (76.5%) of these patients. Conclusions: In the majority of paraneoplastic neurological syndromes patients, the onset of disease is subacute or chronic with mild clinical symptoms. Nervous system lesions usually occur prior to occult tumors with complicated and various clinical manifestations. Neither tumor markers nor onconeural antibodies exhibit a high rate of occurrence, while repeated whole-body screening is helpful in identifying occult tumors. Early diagnosis and treatment are crucial to these patients.
1 June 2023 in Journal of Biobased Materials and Bioenergy
Through orthogonal test and single factor experiment, biochar (BC) was ready by exploitation cyanobacterial sludge and bagasse to explore the potential of changing completely different energy at different carbonization temperatures and the result of Cr(VI) removal by BC. Biochar was prepared from dried cyanobacterial sludge and bagasse under 500 °C, 400 °C and 300 °C at 3.0 h, 2.5 h and 2.0 h under high temperature limited oxygen, respectively. Orthogonal experiments were used to conduct L9(34) three-factor and three-level experiments. Combined with single factor experiments, the optimal combination conditions for Cr(VI) removal were explored. Solid-state energy mainly was in the form of biochar yield. Higher temperature and content of biochar from bagasse had lower solid-state energy by biochar yield (44.00%±0.35%). Cyanobacterial sludge has wide application prospect and nice potential and application prospect in energy conversion. The dismissal of Cr(VI) with biochar was the primary to extend, and so decrease with the rise of charring temperature. The highest expulsion of Cr(VI) was attained once the mass quantitative relation of mixed biochar was 3:1. With a charring time of 2.5 hours, a charring temperature of 400 °C, and a biochar mass quantitative relation of 3:1, up to 98% of Cr(VI) was removed most effectively. Medium temperature biochar and biochar prepared from the mixture of cyanobacteria sludge and bagasse are beneficial to the production of solid energy. Cyanobacterial sludge-based biochar has broad application prospects, especially in energy conversion. In the orthogonal experiment, the sequence of influences of various factors on Cr(VI) removal rate was as follows: carbonation temperature > carbonation time > biochar ratio. The following were the ideal conditions for removing Cr(VI) from biochar: acieration temperature (400 °C), acieration time (2.5 hours), and biochar mass-quantity ratio of 3:1.